Skip to main content

Table 1 Baseline demographics and genetic characteristics

From: Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)

 

AS deletion (N = 40)

AS nondeletion (N = 15)

AS 1–4 years (N = 16)

AS 5–12 years (N = 27)

AS ≥ 18 years (N = 12)

TDC (N = 20)

Sex, n (%)

 Male

20 (50.0)

11 (73.3)

10 (62.5)

16 (59.3)

5 (41.7)

10 (50.0)

 Female

20 (50.0)

4 (26.7)

6 (37.5)

11 (40.7)

7 (58.3)

10 (50.0)

Mean age, years ± SD

(med; min–max)

10.5 ± 8.7

(7.8; 1–31)

9.9 ± 8.7

(8.7; 3–38)

2.9 ± 0.9

(3.0; 1–5)

8.3 ± 2.1

(8.2; 5–13)

24.9 ± 5.9

(24.7; 18–38)

6.5 ± 3.4

(6.5; 1–13)

Age group, n (%)

 1–4 years

13 (32.5)

3 (20.0)

16 (100.0)

0 (0.0)

0 (0.0)

9 (45.0)

 5–12 years

17 (42.5)

10 (66.7)

0 (0.0)

27 (100.0)

0 (0.0)

11 (55.0)

  ≥ 18 years

10 (25.0)

2 (13.3)

0 (0.0)

0 (0.0)

12 (100.0)

0 (0.0)

Race, n (%)

 Asian

1 (2.5)

1 (6.7)

0 (0.0)

1 (3.7)

1 (8.3)

0 (0.0)

 Black or African American

3 (7.5)

0 (0.0)

0 (0.0)

1 (3.7)

2 (16.7)

1 (5.0)

 White

34 (85.0)

13 (86.7)

14 (87.5)

24 (88.9)

9 (75.0)

16 (80.0)

 Multiple

2 (5.0)

1 (6.7)

2 (12.5)

1 (3.7)

0 (0.0)

3 (15.0)

Ethnicity, n (%)

 Hispanic or Latino

7 (17.5)

5 (33.3)

1 (6.3)

9 (33.3)

2 (16.7)

5 (25.0)

 Not Hispanic or Latino

33 (82.5)

10 (66.7)

15 (93.8)

18 (66.7)

10 (83.3)

15 (75.0)

Mean weight, kg ± SD

(med; min–max)

31.8 ± 21.3

(24.5; 9.8–82.3)

33.1 ± 20.0

(28.2; 14.0–90.8)

13.6 ± 2.6

(14.2; 9.8– 18.1)

28.6 ± 8.4

(27.2; 15.7– 55.0)

64.8 ± 16.0

(62.5; 42.6– 90.8)

23.9 ± 10.5

(21.2; 11.5–47.4)

Mean height, cm ± SD

(med; min–max)

121.6 ± 26.9*

(124.0; 79.0–179.0)

127.1 ± 24.6

(124.0; 91.0–170.0)

92.0 ± 7.6

(92.5; 79.0–106.0)

126.7 ± 12.1

(126.0; 107.0–151.0)

159.6 ± 10.1

(158.0; 144.0–179.0)

118.2 ± 24.9

(117.5; 77.0–165.0)

Mean BMI, kg/m2 ± SD

(med; min–max)

18.5 ± 4.7

(17.2; 13.0–31.1)

19.0 ± 3.9

(18.3; 15.8–31.4)

16.0 ± 1.5

(16.2; 13.0–18.8)

17.5 ± 2.5

(17.2; 13.5–25.1)

24.8 ± 4.8

(24.0; 18.4–31.4)

16.5 ± 1.9

(16.6; 12.4–21.5)

Mean head circumference, cm ± SD

(med; min–max)

51.1 ± 3.4

(51.5; 45.0–59.0)

51.3 ± 3.6

(51.5; 46.0–58.7)

47.6 ± 1.9

(47.6; 45.0–52.0)

51.6 ± 2.4

(51.5; 47.8–58.0)

54.9 ± 2.4

(54.8; 52.0–59.0)

52.9 ± 2.8†

(53.5; 47.0–57.0)

Genetic variation detected, n (%)

 Class 1 deletion

19 (47.5)

0 (0.0)

9 (56.3)

6 (22.2)

4 (33.3)

N/A

 Class 2 deletion

19 (47.5)

0 (0.0)

3 (18.8)

10 (37.0)

6 (50.0)

N/A

 Atypical deletion (Class 3 and Class 4)

2 (5.0)

0 (0.0)

1 (6.3)

1 (3.7)

0 (0.0)

N/A

 ID

0 (0.0)

4 (26.7)

0 (0.0)

3 (11.1)

1 (8.3)

N/A

 UBE3A mutation

0 (0.0)

5 (33.3)

1 (6.3)

4 (14.8)

0 (0.0)

N/A

 UPD

0 (0.0)

5 (33.3)

2 (12.5)

3 (11.1)

0 (0.0)

N/A

 Not defined (UPD or ID)

0 (0.0)

1 (6.7)

0 (0.0)

0 (0.0)

1 (8.3)

N/A

  1. AS Angelman syndrome, BMI Body mass index, ID Imprinting defect, Max Maximum, Med Median, Min Minimum, N/A Not assessed, SD Standard deviation, TDC Typically developing children, UBE3A Ubiquitin-protein ligase E3A, UPD Uniparental disomy
  2. *n = 39, †n = 19